Editas Medicine, Inc. (EDIT)
3.02
-0.05
(-1.63%)
USD |
NASDAQ |
Sep 02, 10:37
Editas Medicine Cash from Operations (TTM) : -119.86M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -119.86M |
| March 31, 2026 | -140.50M |
| December 31, 2025 | -165.24M |
| September 30, 2025 | -179.62M |
| June 30, 2025 | -201.36M |
| March 31, 2025 | -208.21M |
| December 31, 2024 | -210.28M |
| September 30, 2024 | -181.76M |
| June 30, 2024 | -164.63M |
| March 31, 2024 | -146.28M |
| December 31, 2023 | -132.18M |
| September 30, 2023 | -152.21M |
| June 30, 2023 | -164.76M |
| March 31, 2023 | -163.89M |
| December 31, 2022 | -177.35M |
| September 30, 2022 | -169.66M |
| June 30, 2022 | -162.44M |
| March 31, 2022 | -163.55M |
| December 31, 2021 | -163.80M |
| September 30, 2021 | -169.32M |
| June 30, 2021 | -183.34M |
| March 31, 2021 | -175.24M |
| Date | Value |
|---|---|
| December 31, 2020 | -179.84M |
| September 30, 2020 | -98.72M |
| June 30, 2020 | -70.80M |
| March 31, 2020 | -65.75M |
| December 31, 2019 | -40.67M |
| September 30, 2019 | -80.37M |
| June 30, 2019 | -61.32M |
| March 31, 2019 | -52.25M |
| December 31, 2018 | -45.71M |
| September 30, 2018 | -72.10M |
| June 30, 2018 | -92.24M |
| March 31, 2018 | -101.67M |
| December 31, 2017 | -9.417M |
| September 30, 2017 | 2.295M |
| June 30, 2017 | 13.23M |
| March 31, 2017 | 29.49M |
| December 31, 2016 | -49.93M |
| September 30, 2016 | -44.54M |
| June 30, 2016 | -39.44M |
| March 31, 2016 | -9.089M |
| December 31, 2015 | -5.403M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -350.48M |
| Geron Corp. | -114.38M |
| Halozyme Therapeutics, Inc. | 818.60M |
| Novavax, Inc. | -36.90M |
| AVITA Medical, Inc. | -24.71M |